(COLM) Columbia Sportswear - Overview
Stock: Apparel, Footwear, Accessories, Equipment
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.97% |
| Yield on Cost 5y | 1.26% |
| Yield CAGR 5y | 3.64% |
| Payout Consistency | 92.9% |
| Payout Ratio | 79.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.7% |
| Relative Tail Risk | -4.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.35 |
| Alpha | -36.76 |
| Character TTM | |
|---|---|
| Beta | 1.049 |
| Beta Downside | 0.992 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.09% |
| CAGR/Max DD | -0.21 |
Description: COLM Columbia Sportswear January 12, 2026
Columbia Sportswear Company (NASDAQ: COLM) designs, develops, markets and distributes outdoor-apparel, footwear and equipment across the Americas, Europe, Asia-Pacific, the Middle East and Africa. Its product portfolio-hiking and trail-running apparel, cold-weather boots, fishing gear and lifestyle footwear-is sold through a mixed wholesale-to-retail model that includes specialty outdoor stores, large sporting-goods chains, department stores, e-commerce platforms and its own branded outlets, with brands that include Columbia, Mountain Hardwear, prAna and SOREL.
In FY 2023 the company reported roughly $4.3 billion in revenue, a 10 % year-over-year increase in e-commerce sales, and an operating margin of about 7 %, reflecting strong demand for outdoor recreation amid rising consumer confidence in discretionary spending. Inventory turnover improved to 3.2×, indicating better supply-chain efficiency, while the broader outdoor-apparel sector is benefitting from a post-pandemic “stay-active” trend that historically adds 3-4 % annual growth to category sales. However, exposure to raw-material price volatility and potential headwinds from inflation-driven cost pressures remain key risks to monitor.
For a deeper quantitative view of COLM’s valuation dynamics, you might explore the analyst tools on ValueRay to see how its forward-looking metrics compare to peers.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 186.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -11.23 > 1.0 |
| NWC/Revenue: 33.70% < 20% (prev 37.79%; Δ -4.10% < -1%) |
| CFO/TA 0.09 > 3% & CFO 234.2m > Net Income 186.6m |
| Net Debt (251.5m) to EBITDA (287.1m): 0.88 < 3 |
| Current Ratio: 2.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.1m) vs 12m ago -4.87% < -2% |
| Gross Margin: 50.40% > 18% (prev 0.50%; Δ 4990 % > 0.5%) |
| Asset Turnover: 125.1% > 50% (prev 120.7%; Δ 4.41% > 0%) |
| Interest Coverage Ratio: -12.93 > 6 (EBITDA TTM 287.1m / Interest Expense TTM -17.9m) |
Altman Z'' 7.07
| A: 0.43 (Total Current Assets 1.75b - Total Current Liabilities 592.7m) / Total Assets 2.71b |
| B: 0.63 (Retained Earnings 1.72b / Total Assets 2.71b) |
| C: 0.08 (EBIT TTM 231.2m / Avg Total Assets 2.74b) |
| D: 1.57 (Book Value of Equity 1.66b / Total Liabilities 1.06b) |
| Altman-Z'' Score: 7.07 = AAA |
Beneish M -3.06
| DSRI: 1.02 (Receivables 610.5m/581.7m, Revenue 3.42b/3.33b) |
| GMI: 0.99 (GM 50.40% / 50.02%) |
| AQI: 0.93 (AQ_t 0.09 / AQ_t-1 0.10) |
| SGI: 1.03 (Revenue 3.42b / 3.33b) |
| TATA: -0.02 (NI 186.6m - CFO 234.2m) / TA 2.71b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of COLM shares?
Over the past week, the price has changed by +14.09%, over one month by +10.30%, over three months by +25.00% and over the past year by -19.24%.
Is COLM a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 5
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the COLM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 59.3 | -5.9% |
| Analysts Target Price | 59.3 | -5.9% |
| ValueRay Target Price | 65 | 3% |
COLM Fundamental Data Overview February 03, 2026
P/E Forward = 18.4502
P/S = 0.8843
P/B = 1.7616
P/EG = 2.66
Revenue TTM = 3.42b USD
EBIT TTM = 231.2m USD
EBITDA TTM = 287.1m USD
Long Term Debt = 480.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 82.7m USD (from shortTermDebt, last quarter)
Debt = 480.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 251.5m USD (from netDebt column, last quarter)
Enterprise Value = 3.27b USD (3.03b + Debt 480.3m - CCE 236.0m)
Interest Coverage Ratio = -12.93 (Ebit TTM 231.2m / Interest Expense TTM -17.9m)
EV/FCF = 19.30x (Enterprise Value 3.27b / FCF TTM 169.5m)
FCF Yield = 5.18% (FCF TTM 169.5m / Enterprise Value 3.27b)
FCF Margin = 4.95% (FCF TTM 169.5m / Revenue TTM 3.42b)
Net Margin = 5.45% (Net Income TTM 186.6m / Revenue TTM 3.42b)
Gross Margin = 50.40% ((Revenue TTM 3.42b - Cost of Revenue TTM 1.70b) / Revenue TTM)
Gross Margin QoQ = 50.01% (prev 49.09%)
Tobins Q-Ratio = 1.21 (Enterprise Value 3.27b / Total Assets 2.71b)
Interest Expense / Debt = 0.86% (Interest Expense 4.13m / Debt 480.3m)
Taxrate = 26.74% (19.0m / 71.0m)
NOPAT = 169.4m (EBIT 231.2m * (1 - 26.74%))
Current Ratio = 2.95 (Total Current Assets 1.75b / Total Current Liabilities 592.7m)
Debt / Equity = 0.29 (Debt 480.3m / totalStockholderEquity, last quarter 1.66b)
Debt / EBITDA = 0.88 (Net Debt 251.5m / EBITDA 287.1m)
Debt / FCF = 1.48 (Net Debt 251.5m / FCF TTM 169.5m)
Total Stockholder Equity = 1.70b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.82% (Net Income 186.6m / Total Assets 2.71b)
RoE = 10.98% (Net Income TTM 186.6m / Total Stockholder Equity 1.70b)
RoCE = 10.61% (EBIT 231.2m / Capital Employed (Equity 1.70b + L.T.Debt 480.3m))
RoIC = 9.96% (NOPAT 169.4m / Invested Capital 1.70b)
WACC = 8.53% (E(3.03b)/V(3.51b) * Re(9.78%) + D(480.3m)/V(3.51b) * Rd(0.86%) * (1-Tc(0.27)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.43%
[DCF Debug] Terminal Value 67.85% ; FCFF base≈294.7m ; Y1≈193.5m ; Y5≈88.3m
Fair Price DCF = 24.65 (EV 1.58b - Net Debt 251.5m = Equity 1.33b / Shares 53.9m; r=8.53% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -27.18 | EPS CAGR: -33.49% | SUE: -4.0 | # QB: 0
Revenue Correlation: -10.77 | Revenue CAGR: -4.69% | SUE: 1.57 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=-0.014 | Revisions Net=+1 | Analysts=7
EPS next Year (2026-12-31): EPS=2.99 | Chg30d=+0.011 | Revisions Net=+1 | Growth EPS=-1.3% | Growth Revenue=+1.8%